Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:19   Issue: 3
Pp: 161-161
M.P. Carty
DOI: 10.2174/156800961903190214151927



Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors promotion: free to download

Volume:19   Issue: 3
Pp: 179-188
Arkene Levy*, Khalid Alhazzani, Priya Dondapati, Ali Alaseem, Khadijah Cheema, Keerthi Thallapureddy, Paramjot Kaur, Saad Alobid and Appu Rathinavelu
DOI: 10.2174/1568009618666180706165222




Macrophage Flipping from Foe to Friend: A Matter of Interest in Breast Carcinoma Heterogeneity Driving Drug Resistance promotion: free to download

Volume:19   Issue: 3
Pp: 189-198
Ishita Tandon and Nilesh Kumar Sharma*
DOI: 10.2174/1568009618666180628102247




Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis

Volume:19   Issue: 3
Pp: 199-209
Bing-Di Yan, Xiao-Feng Cong, Sha-Sha Zhao, Meng Ren, Zi-Ling Liu, Zhi Li, Chen Chen and Lei Yang*
DOI: 10.2174/1568009618666180430124738




Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients’ Outcome promotion: free to download

Volume:19   Issue: 3
Pp: 210-221
Karthikeyan Subbarayan and Barbara Seliger*
DOI: 10.2174/1568009618666180706165845




The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine

Volume:19   Issue: 3
Pp: 222-230
Gracia Montag, Helga Stopper, Quoc Anh Ngo and Henning Hintzsche*
DOI: 10.2174/1568009618666180430142233



Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway

Volume:19   Issue: 3
Pp: 231-242
Md Zahidul I. Pranjol, Nicholas J. Gutowski, Michael Hannemann and Jacqueline L. Whatmore*
DOI: 10.2174/1568009618666180831123951